T-cell replete allogeneic stem cell transplant for mantle cell lymphoma achieves durable disease control, including against TP53-mutated disease

Saved in:
Bibliographic Details
Published in:Bone marrow transplantation (Basingstoke) 2021-11, Vol.56 (11), p.2857-2859
Main Authors: Lew, Thomas E., Cliff, Edward R. S., Dickinson, Michael, Tam, Constantine S., Seymour, John F., Blombery, Piers, Bajel, Ashish, Ritchie, David, Khot, Amit
Format: Article
Language:English
Subjects:
13/100
45/23
631/67/1059/2325
692/308/2171
Adult
Care and treatment
Cell Biology
Correspondence
Disease control
Health aspects
Hematology
Hematopoietic Stem Cell Transplantation
Hematopoietic stem cells
Humans
Internal Medicine
Lymphocytes T
Lymphoma
Lymphoma, Mantle-Cell - genetics
Lymphoma, Mantle-Cell - therapy
Lymphomas
Mantle cell lymphoma
Medicine
Medicine & Public Health
Public Health
Stem Cell Transplantation
Stem Cells
T cells
T-Lymphocytes - pathology
Transplantation
Transplantation, Homologous
Tumor Suppressor Protein p53 - genetics
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0268-3369
1476-5365
DOI:10.1038/s41409-021-01418-3